BioSpace News Archive

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that company management is scheduled to webcast a presentation from the UBS Global Healthcare Conference.

IPO bolsters balance sheet to $160 million in cash and cash equivalents; expected to fund operations at least into the second half of 2023

Creating a movement from the inside out – to break the stigma of mental health conditions and empower employees to be champions of brain health

The global contact lens market is projected to witness considerable rise owing to rising prevalence of increased preference for contact lenses over prescribed eyeglasses for aesthetics purposes and rising cases of vision related problems like myopia.

Development of novel extended oral antibiotics and molecules to treat antibiotic-resistant prosthetic infections is forecast to elevate market growth.

XPhyto Therapeutics Corp. is pleased to announce that its distribution, storage and logistics partner, Max Pharma GmbH, will launch the sale of its 25-minute SARS-CoV-2 RT-PCR test system in Germany next week.

The growing prevalence of chronic diseases, infections, and disorders are urging many individuals to get tested for any ailments or health problems at an earlier stage.

First clinical trial from Crescendo’s proprietary pipeline of novel, targeted T cell enhancing Humabody® therapeutics; initial clinical data expected in 2022

Arecor Limited, the biopharmaceutical company advancing today’s therapies to enable healthier lives, announces that it has signed a formulation study partnership with Eli Lilly and Company.

NeoImmuneTech, Inc. (KOSDAQ: 950220), a clinical-stage T cell-focused biopharmaceutical company, today announced that new data from two clinical trials evaluating the company’s lead asset NT-I7 (efineptakin alfa) will be presented during poster sessions at the American Society of Clinical Oncology (ASCO) annual meeting, to be held in a virtual platform June 4-8, 2021.